Vaibhav Jewellers IPO | Its shares were available at around 3-5 percent premium over the issue price, in the grey market, an unofficial platform for trading in IPO shares till the listing, analysts on anonymity said.
The real action will be seen in the SME segment as 12 IPOs worth Rs 431-crore are ready to be launched next week, with five of them opening on September 25.
The two companies filed their preliminary IPO papers with the capital markets regulator between August and September and obtained their observation letters during November 28-December 2.
Concord is among the leading manufacturers of fermentation-based biopharmaceutical APIs focused on niche segments, such as immunosuppressant, oncology, anti-fungal and anti-bacterial.
New Delhi, Dec 6: Rare Enterprises-backed Concord Biotech and regional jewellery brand Vaibhav Gems N’ Jewellers have received capital markets regulator Sebi’s go-ahead to raise funds through initial public offerings (IPOs). The two companies filed their preliminary IPO papers with the capital markets regulator between August and September and obtained their observation letters during November 28-December 2, an update with the Securities and Exchange Board of India (Sebi) showed on Tuesday. In Sebi’s parlance, its observations imply its go-ahead to […]